The human-based protein Elastatropin and technology involving adipose-derived stem cells and stromal cell culture media will be used to develop cellular treatments for wound healing and regenerative therapies. American CryoStem and Protein Genomics have formed a partnership that will focus on therapies for difficult-to-treat conditions.
Partnership will pursue cellular therapies for hard-to-treat wounds
SmartBrief Job Listings for Health Care
|President/Chief Executive Officer||
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Director, Payer Marketing||
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Chief Medical Officer, Texas Children's Health Plan||
Cejka Executive Search for Texas Childre's Health Plan